STIM vs. KMTS, INMD, MDXG, SIBN, IRMD, CBLL, BBNX, AVNS, EMBC, and BVS
Should you be buying Neuronetics stock or one of its competitors? The main competitors of Neuronetics include Kestra Medical Technologies (KMTS), InMode (INMD), MiMedx Group (MDXG), SiBone (SIBN), iRadimed (IRMD), CeriBell (CBLL), Beta Bionics (BBNX), Avanos Medical (AVNS), Embecta (EMBC), and Bioventus (BVS). These companies are all part of the "medical equipment" industry.
Neuronetics vs. Its Competitors
Neuronetics (NASDAQ:STIM) and Kestra Medical Technologies (NASDAQ:KMTS) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, dividends, earnings, profitability, valuation and institutional ownership.
Kestra Medical Technologies has a net margin of 0.00% compared to Neuronetics' net margin of -53.67%. Kestra Medical Technologies' return on equity of 0.00% beat Neuronetics' return on equity.
In the previous week, Kestra Medical Technologies had 5 more articles in the media than Neuronetics. MarketBeat recorded 5 mentions for Kestra Medical Technologies and 0 mentions for Neuronetics. Kestra Medical Technologies' average media sentiment score of 0.36 beat Neuronetics' score of 0.00 indicating that Kestra Medical Technologies is being referred to more favorably in the news media.
Kestra Medical Technologies has lower revenue, but higher earnings than Neuronetics.
53.6% of Neuronetics shares are owned by institutional investors. 8.7% of Neuronetics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Neuronetics currently has a consensus target price of $5.50, indicating a potential upside of 61.53%. Kestra Medical Technologies has a consensus target price of $27.50, indicating a potential upside of 75.49%. Given Kestra Medical Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Kestra Medical Technologies is more favorable than Neuronetics.
Summary
Kestra Medical Technologies beats Neuronetics on 8 of the 11 factors compared between the two stocks.
Get Neuronetics News Delivered to You Automatically
Sign up to receive the latest news and ratings for STIM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding STIM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Neuronetics Competitors List
Related Companies and Tools
This page (NASDAQ:STIM) was last updated on 7/3/2025 by MarketBeat.com Staff
Free STIM Stock Alerts